Lymphoedema is a condition in which an accumulation of protein-rich fluid in the tissues causes swelling in one or more areas of the body.

Damage to the lymphatic system can occur as a result of cancer treatment, including surgery involving lymph node removal, radiotherapy or chemotherapy.

While lymphoedema is a chronic condition and currently has no cure, early diagnosis and appropriate management can help reduce symptoms, improve function, and minimise progression.

Services provided

• Prospective surveillance for patients at risk of cancer-related lymphoedema, including pre-operative baseline assessment, regular post-operative monitoring, and screening using the SOZO device to support early detection and intervention.
• Assessment and management of lymphoedema. 
• Scar management. 
• Pre- and post-surgical exercise prescription. 
• Prescription and fitting of compression garments. 
• Education and advice to support the early identification of lymphoedema and loss of function related to cancer treatment. 
• Early identification of subclinical lymphoedema allows intervention at the earliest stages and may reduce the risk of progression to chronic lymphoedema.

Early detection matters

Cancer-related lymphoedema can develop months or years after treatment. Early detection through regular monitoring allows timely intervention and may reduce the severity and long-term impact of lymphoedema. Ongoing screening occurs for 5 years post-surgery.

A pre-operative assessment allows us to obtain baseline measures and provide education before your hospital admission. This appointment is covered under your admission with no additional cost.

The clinic uses the SOZO device as part of a suite of clinical tools for the assessment and management of patients at risk of developing lymphoedema, as well as those with diagnosed lymphoedema. The SOZO device uses bioimpedance spectroscopy (BIS) technology to assess fluid status and tissue composition and generate an L-Dex score to assist in the early detection and monitoring of cancer-related lymphoedema.

This quick, 30-second, non-invasive test supports proactive patient care through:

• Early detection of lymphoedema. 
• Monitoring of treatment progress. 
• Enhanced patient education and support. 

The SOZO device was generously donated by Blush Cancer Care and enables us to provide up-to-date and accurate lymphoedema screening for our patients.